BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 21825147)

  • 1. Antagonistic VEGF variants engineered to simultaneously bind to and inhibit VEGFR2 and alphavbeta3 integrin.
    Papo N; Silverman AP; Lahti JL; Cochran JR
    Proc Natl Acad Sci U S A; 2011 Aug; 108(34):14067-72. PubMed ID: 21825147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Necl-5/poliovirus receptor interacts with VEGFR2 and regulates VEGF-induced angiogenesis.
    Kinugasa M; Amano H; Satomi-Kobayashi S; Nakayama K; Miyata M; Kubo Y; Nagamatsu Y; Kurogane Y; Kureha F; Yamana S; Hirata K; Miyoshi J; Takai Y; Rikitake Y
    Circ Res; 2012 Mar; 110(5):716-26. PubMed ID: 22282193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineered cystine-knot peptides that bind alpha(v)beta(3) integrin with antibody-like affinities.
    Silverman AP; Levin AM; Lahti JL; Cochran JR
    J Mol Biol; 2009 Jan; 385(4):1064-75. PubMed ID: 19038268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial-cadherin stimulates syndecan-1-coupled insulin-like growth factor-1 receptor and cross-talk between αVβ3 integrin and vascular endothelial growth factor receptor 2 at the onset of endothelial cell dissemination during angiogenesis.
    Rapraeger AC; Ell BJ; Roy M; Li X; Morrison OR; Thomas GM; Beauvais DM
    FEBS J; 2013 May; 280(10):2194-206. PubMed ID: 23331867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant RGD-disintegrin DisBa-01 blocks integrin α
    Danilucci TM; Santos PK; Pachane BC; Pisani GFD; Lino RLB; Casali BC; Altei WF; Selistre-de-Araujo HS
    Cell Commun Signal; 2019 Mar; 17(1):27. PubMed ID: 30894182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen activator inhibitor-1 inhibits angiogenic signaling by uncoupling vascular endothelial growth factor receptor-2-αVβ3 integrin cross talk.
    Wu J; Strawn TL; Luo M; Wang L; Li R; Ren M; Xia J; Zhang Z; Ma W; Luo T; Lawrence DA; Fay WP
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):111-20. PubMed ID: 25378411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial SCUBE2 Interacts With VEGFR2 and Regulates VEGF-Induced Angiogenesis.
    Lin YC; Chao TY; Yeh CT; Roffler SR; Kannagi R; Yang RB
    Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):144-155. PubMed ID: 27834687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of αvβ3 integrin in gremlin-induced angiogenesis.
    Ravelli C; Mitola S; Corsini M; Presta M
    Angiogenesis; 2013 Jan; 16(1):235-43. PubMed ID: 23053782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rap1 promotes VEGFR2 activation and angiogenesis by a mechanism involving integrin αvβ₃.
    Lakshmikanthan S; Sobczak M; Chun C; Henschel A; Dargatz J; Ramchandran R; Chrzanowska-Wodnicka M
    Blood; 2011 Aug; 118(7):2015-26. PubMed ID: 21636859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endorepellin laminin-like globular 1/2 domains bind Ig3-5 of vascular endothelial growth factor (VEGF) receptor 2 and block pro-angiogenic signaling by VEGFA in endothelial cells.
    Willis CD; Poluzzi C; Mongiat M; Iozzo RV
    FEBS J; 2013 May; 280(10):2271-84. PubMed ID: 23374253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineered cystine knot peptides that bind alphavbeta3, alphavbeta5, and alpha5beta1 integrins with low-nanomolar affinity.
    Kimura RH; Levin AM; Cochran FV; Cochran JR
    Proteins; 2009 Nov; 77(2):359-69. PubMed ID: 19452550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of integrin-vascular endothelial growth factor receptor cross-activation in angiogenesis.
    Mahabeleshwar GH; Feng W; Reddy K; Plow EF; Byzova TV
    Circ Res; 2007 Sep; 101(6):570-80. PubMed ID: 17641225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual-targeted contrast agent for US assessment of tumor angiogenesis in vivo.
    Willmann JK; Lutz AM; Paulmurugan R; Patel MR; Chu P; Rosenberg J; Gambhir SS
    Radiology; 2008 Sep; 248(3):936-44. PubMed ID: 18710985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blocking αvβ3 integrin by a recombinant RGD disintegrin impairs VEGF signaling in endothelial cells.
    Montenegro CF; Salla-Pontes CL; Ribeiro JU; Machado AZ; Ramos RF; Figueiredo CC; Morandi V; Selistre-de-Araujo HS
    Biochimie; 2012 Aug; 94(8):1812-20. PubMed ID: 22561350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substrate-immobilized HIV-1 Tat drives VEGFR2/α(v)β(3)-integrin complex formation and polarization in endothelial cells.
    Urbinati C; Ravelli C; Tanghetti E; Belleri M; Giacopuzzi E; Monti E; Presta M; Rusnati M
    Arterioscler Thromb Vasc Biol; 2012 May; 32(5):e25-34. PubMed ID: 22362758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineered ligand-based VEGFR antagonists with increased receptor binding affinity more effectively inhibit angiogenesis.
    Kapur S; Silverman AP; Ye AZ; Papo N; Jindal D; Blumenkranz MS; Cochran JR
    Bioeng Transl Med; 2017 Mar; 2(1):81-91. PubMed ID: 28516164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The promotion of endothelial cell attachment and spreading using FNIII10 fused to VEGF-A165.
    Traub S; Morgner J; Martino MM; Höning S; Swartz MA; Wickström SA; Hubbell JA; Eming SA
    Biomaterials; 2013 Aug; 34(24):5958-68. PubMed ID: 23683723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pleiotrophin selectively binds to vascular endothelial growth factor receptor 2 and inhibits or stimulates cell migration depending on α
    Lamprou M; Kastana P; Kofina F; Tzoupis Η; Barmpoutsi S; Sajib MS; Koutsioumpa M; Poimenidi E; Zompra AA; Tassopoulos D; Choleva E; Tselios T; Mikelis CM; Papadimitriou E
    Angiogenesis; 2020 Nov; 23(4):621-636. PubMed ID: 32681389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological and molecular properties of a new alpha(v)beta3/alpha(v)beta5 integrin antagonist.
    Belvisi L; Riccioni T; Marcellini M; Vesci L; Chiarucci I; Efrati D; Potenza D; Scolastico C; Manzoni L; Lombardo K; Stasi MA; Orlandi A; Ciucci A; Nico B; Ribatti D; Giannini G; Presta M; Carminati P; Pisano C
    Mol Cancer Ther; 2005 Nov; 4(11):1670-80. PubMed ID: 16275988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of the receptor binding profiles of the vascular endothelial growth factors on their angiogenic features.
    Nieminen T; Toivanen PI; Rintanen N; Heikura T; Jauhiainen S; Airenne KJ; Alitalo K; Marjomäki V; Ylä-Herttuala S
    Biochim Biophys Acta; 2014 Jan; 1840(1):454-63. PubMed ID: 24112971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.